Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 17:00 ET | Source: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1...
April 01, 2026 12:00 ET | Source: Ipsen Pharma

Ipsen annonce la mise à disposition de son Document d’enregistrement universel 2025

Ipsen annonce la mise à disposition de son Document d’enregistrement universel 2025 PARIS, FRANCE, 1er AVRIL 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce que son Document d’enregistrement...
April 01, 2026 12:00 ET | Source: Ipsen Pharma

Ipsen announces the availability of its 2025 Universal Registration Document

Ipsen announces the availability of its 2025 Universal Registration Document PARIS, FRANCE, 1 APRIL 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced that its 2025 Universal Registration Document...
April 01, 2026 09:17 ET | Source: NurExone Biologic Inc

NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy

TORONTO and HAIFA, Israel, April 01, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotechnology company developing...
April 01, 2026 09:00 ET | Source: Beyond Air™

Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)

GARDEN CITY, N.Y., April 01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide...
April 01, 2026 09:00 ET | Source: Orion Oyj

Muutos Orion-konsernin johtoryhmässä 8.4.2026 lukien – Berkeley Vincent nimitetty Innovative Medicines -yksikön johtajaksi

ORION OYJ PÖRSSITIEDOTE – MUUTOKSET HALLITUS/JOHTO/TILINTARKASTUS1.4.2026 KLO 16.00 Muutos Orion-konsernin johtoryhmässä 8.4.2026 lukien – Berkeley Vincent nimitetty Innovative...
April 01, 2026 09:00 ET | Source: Orion Oyj

Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines

ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS1 APRIL 2026 at 16.00 EEST Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed...
April 01, 2026 08:30 ET | Source: BioSyent Inc.

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

MISSISSAUGA, Ontario, April 01, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® has been named the #1 recommended over-the-counter (OTC)...
April 01, 2026 08:30 ET | Source: BioSyent Inc.

FeraMAX est le supplemént de fer le plus recommandé au Canada depuis 11 années consécutives

MISSISSAUGA, Ontario, 01 avr. 2026 (GLOBE NEWSWIRE) -- BioSyent inc. (« BioSyent », Bourse de croissance TSX : RX) est heureuse d’annoncer que FeraMAXMD a été désigné supplément de fer en vente...
April 01, 2026 07:00 ET | Source: Tilray Brands, Inc.

Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year

International Cannabis Accelerates with 73% Net Revenue Growth and 100% Increase in Cannabis Flower Sales Volume Year-Over-Year Canadian Adult-Use and Medical Cannabis Net Revenue Combined Increased...